Pertussis (Whooping Cough)

被引:62
作者
Decker, Michael D. [1 ]
Edwards, Kathryn M. [2 ]
机构
[1] Vanderbilt Univ, Med Ctr, Dept Hlth Policy, Nashville, TN USA
[2] Vanderbilt Univ, Dept Pediat, Div Infect Dis, Med Ctr, Nashville, TN USA
关键词
pertussis; pertussis vaccine; vaccine-preventable diseases; whooping cough; UNITED-STATES; VACCINES; DISEASE; TRANSMISSION; ADOLESCENTS; DIPHTHERIA; PROTECT; TETANUS;
D O I
10.1093/infdis/jiaa469
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Pertussis (whooping cough) is a respiratory infection caused by Bordetella pertussis. All ages are susceptible. In the prevaccine era, almost all children became infected. Pertussis is particularly dangerous in young infants, who account for practically all hospitalizations and deaths, but clinical disease is burdensome at any age. Widespread use of pertussis vaccines dramatically reduced cases, but concern over adverse reactions led to the replacement of standard whole-cell by acellular pertussis vaccines that contain only a few selected pertussis antigens and are far less reactogenic. Routine administration of acellular pertussis vaccines combined with diphtheria and tetanus toxoids is recommended in infancy with toddler and preschool boosters, at age 11, and during pregnancy. Boosting in the second half of every pregancy is critical to protection of the newborn. Waning of vaccine immunity over time has become an increasing concern, and several new pertussis vaccines are being evaluated to address this problem.
引用
收藏
页码:S310 / S320
页数:11
相关论文
共 15 条
[1]  
Acosta AM, 2015, PEDIATRICS, V135, P981, DOI [10.1542/peds.2014-4118, 10.1542/peds.2014-3358]
[2]   Th1/Th17 polarization persists following whole-cell pertussis vaccination despite repeated acellular boosters [J].
Antunes, Ricardo da Silva ;
Babor, Mariana ;
Carpenter, Chelsea ;
Khalil, Natalie ;
Cortese, Mario ;
Mentzer, Alexander J. ;
Seumois, Gregory ;
Petro, Christopher D. ;
Purcell, Lisa A. ;
Vijayanand, Pandurangan ;
Crotty, Shane ;
Pulendran, Bali ;
Peters, Bjoern ;
Sette, Alessandro .
JOURNAL OF CLINICAL INVESTIGATION, 2018, 128 (09) :3853-3865
[3]  
DECKER MD, 1995, PEDIATRICS, V96, P557
[4]  
EDWARDS KM, 1995, PEDIATRICS, V96, P548
[5]  
Edwards KM, 2017, Vaccines, V7th, P711
[6]   Changing epidemiology of pertussis in the United States:: Increasing reported incidence among adolescents and adults, 1990-1996 [J].
Güris, D ;
Strebel, PM ;
Bardenheier, B ;
Brennan, M ;
Tachdjian, R ;
Finch, E ;
Wharton, M ;
Livengood, JR .
CLINICAL INFECTIOUS DISEASES, 1999, 28 (06) :1230-1237
[7]   ADVERSE EVENTS FOLLOWING PERTUSSIS AND RUBELLA VACCINES - SUMMARY OF A REPORT OF THE INSTITUTE-OF-MEDICINE [J].
HOWSON, CP ;
FINEBERG, HV .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1992, 267 (03) :392-396
[8]  
Liang JL, 2018, MMWR RECOMM REP, V67, P1, DOI 10.15585/mmwr.rr6702a1
[9]   New pertussis vaccination approaches: en route to protect newborns? [J].
Locht, Camille ;
Mielcarek, Nathalie .
FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY, 2012, 66 (02) :121-133
[10]   Pertussis disease and transmission and host responses: insights from the baboon model of pertussis [J].
Pinto, Marta V. ;
Merkel, Tod J. .
JOURNAL OF INFECTION, 2017, 74 :S114-S119